Tag: Depo-Provera Liability Litigation

MDL 3140 Alert: The “Silent Risk” in Your 2026 Portfolio
February 7, 2026 by Mohr Marketing Pfizer. $3B+ Liquidity. 74 Million Users. Is your intake ready for the Depo-Provera docket? Usage Duration Verification The science relies on “cumulative dose.” We strictly screen for the “Duration of Use” criteria. The 1-Year Rule: Our funnels automatically reject cases where the user only received one or two injections. Re-Injection Confirmation: We verify that the… Continue reading MDL 3140 Alert: The “Silent Risk” in Your 2026 Portfolio
Get Signed, Vetted Meningioma Cases with the Compliance Shield
February 6, 2026 by Mohr Marketing 🛑 Stop Wasting Intake on “Headache” Calls (Depo-Provera Solution) The Depo-Provera MDL (3140) is moving fast. The science is strong (5.6x risk of Meningioma), and the defendant is solvent (Pfizer). But if you are buying raw leads, you are likely burning your intake team out on non-qualifying injuries. Stop buying “maybes.” Start buying Retainers. At… Continue reading Get Signed, Vetted Meningioma Cases with the Compliance Shield
“Compliance Shield” Protocol for Depo-Provera MDL 3140
February 5, 2026 by Mohr Marketing “Compliance Shield” Protocol to Deliver Verified, Signed Plaintiffs for Depo-Provera MDL 3140 As the legal industry turns its attention to the rapidly maturing MDL 3140: In re: Depo-Provera Products Liability Litigation, Mohr Marketing announces the immediate availability of a specialized signed case acquisition program. This new offering allows law firms to build their pharmaceutical liability… Continue reading “Compliance Shield” Protocol for Depo-Provera MDL 3140
How to Build a High-Value Depo-Provera Docket (Intake Strategy)
February 4, 2026 by Mohr Marketing The Silent Signal: Why the Depo-Provera MDL is Your Firm’s Next Critical Docket With the docketing of MDL 3140 (In re: Depo-Provera Liability Litigation), firms have a massive opportunity to diversify their 2026 inventory—but only if they can solve the “Intake Integrity” challenge. Somewhere between the latest mass tort filings and the industry’s focus on… Continue reading How to Build a High-Value Depo-Provera Docket (Intake Strategy)
Secret Link